These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc. Forbes CJ; Lowry D; Geer L; Veazey RS; Shattock RJ; Klasse PJ; Mitchnick M; Goldman L; Doyle LA; Muldoon BC; Woolfson AD; Moore JP; Malcolm RK J Control Release; 2011 Dec; 156(2):161-9. PubMed ID: 21864598 [TBL] [Abstract][Full Text] [Related]
3. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action. Fetherston SM; Boyd P; McCoy CF; McBride MC; Edwards KL; Ampofo S; Malcolm RK Eur J Pharm Sci; 2013 Feb; 48(3):406-15. PubMed ID: 23266465 [TBL] [Abstract][Full Text] [Related]
4. Electrospun solid dispersions of Maraviroc for rapid intravaginal preexposure prophylaxis of HIV. Ball C; Woodrow KA Antimicrob Agents Chemother; 2014 Aug; 58(8):4855-65. PubMed ID: 24913168 [TBL] [Abstract][Full Text] [Related]
5. A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice. Neff CP; Kurisu T; Ndolo T; Fox K; Akkina R PLoS One; 2011; 6(6):e20209. PubMed ID: 21673796 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques. Malcolm RK; Forbes CJ; Geer L; Veazey RS; Goldman L; Klasse PJ; Moore JP J Antimicrob Chemother; 2013 Mar; 68(3):678-83. PubMed ID: 23111849 [TBL] [Abstract][Full Text] [Related]
7. Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques. Malcolm RK; Veazey RS; Geer L; Lowry D; Fetherston SM; Murphy DJ; Boyd P; Major I; Shattock RJ; Klasse PJ; Doyle LA; Rasmussen KK; Goldman L; Ketas TJ; Moore JP Antimicrob Agents Chemother; 2012 May; 56(5):2251-8. PubMed ID: 22330914 [TBL] [Abstract][Full Text] [Related]
8. Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections. Timur SS; Şahin A; Aytekin E; Öztürk N; Polat KH; Tezel N; Gürsoy RN; Çalış S Pharm Dev Technol; 2018 Mar; 23(3):301-310. PubMed ID: 28503983 [TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic Activity of Dapivirine and Maraviroc Single Entity and Combination Topical Gels for HIV-1 Prevention. Dezzutti CS; Yandura S; Wang L; Moncla B; Teeple EA; Devlin B; Nuttall J; Brown ER; Rohan LC Pharm Res; 2015 Nov; 32(11):3768-81. PubMed ID: 26078001 [TBL] [Abstract][Full Text] [Related]
10. Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro. Lai BE; Geonnotti AR; Desoto MG; Montefiori DC; Katz DF Antiviral Res; 2010 Nov; 88(2):143-51. PubMed ID: 20709109 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the Protein Microbicide 5P12-RANTES in Sheep following Single-Dose Vaginal Gel Administration. McBride JW; Dias N; Cameron D; Offord RE; Hartley O; Boyd P; Kett VL; Malcolm RK Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784672 [TBL] [Abstract][Full Text] [Related]
12. Formulation and delivery of microbicides. Agashe H; Hu M; Rohan L Curr HIV Res; 2012 Jan; 10(1):88-96. PubMed ID: 22264050 [TBL] [Abstract][Full Text] [Related]
13. Formulation development and evaluation of innovative two-polymer (SR-2P) bioadhesive vaginal gel. Podaralla S; Alt C; Shankar GN AAPS PharmSciTech; 2014 Aug; 15(4):928-38. PubMed ID: 24781671 [TBL] [Abstract][Full Text] [Related]
14. Sustained release of the candidate antiretroviral peptides T-1249 and JNJ54310516-AFP from a rod insert vaginal ring. Murphy DJ; Amssoms K; Pille G; Clarke A; O'Hara M; van Roey J; Malcolm RK Drug Deliv Transl Res; 2016 Jun; 6(3):234-42. PubMed ID: 26787615 [TBL] [Abstract][Full Text] [Related]
15. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal. Karimunnisa S; Atmaram P Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766 [TBL] [Abstract][Full Text] [Related]
16. Coaxially electrospun fiber-based microbicides facilitate broadly tunable release of maraviroc. Ball C; Chou SF; Jiang Y; Woodrow KA Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():117-24. PubMed ID: 27040202 [TBL] [Abstract][Full Text] [Related]
17. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869 [TBL] [Abstract][Full Text] [Related]
18. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1. Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474 [TBL] [Abstract][Full Text] [Related]